Operating Lease, Right-of-Use Asset of COLLEGIUM PHARMACEUTICAL, INC from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
COLLEGIUM PHARMACEUTICAL, INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • COLLEGIUM PHARMACEUTICAL, INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,432,000, a 28% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

COLLEGIUM PHARMACEUTICAL, INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,432,000 -$1,737,000 -28% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $5,263,000 -$329,000 -5.9% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $5,545,000 -$268,000 -4.6% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $5,822,000 -$207,000 -3.4% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $6,169,000 -$74,000 -1.2% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $5,592,000 -$860,000 -13% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $5,813,000 -$845,000 -13% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $6,029,000 -$832,000 -12% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $6,243,000 -$818,000 -12% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $6,452,000 -$805,000 -11% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $6,658,000 -$1,154,000 -15% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $6,861,000 -$783,000 -10% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $7,061,000 -$774,000 -9.9% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $7,257,000 -$766,000 -9.5% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $7,812,000 -$397,000 -4.8% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $7,644,000 -$747,000 -8.9% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $7,835,000 -$737,000 -8.6% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $8,023,000 -$674,000 -7.8% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $8,209,000 -$664,000 -7.5% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $8,391,000 -$656,000 -7.3% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $8,572,000 -$647,000 -7% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $8,697,000 -$877,000 -9.2% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $8,873,000 -$893,000 -9.1% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $9,047,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $9,219,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $9,574,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $9,766,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.